The American journal of managed care
-
In an attempt to increase the efficiency of their drug benefit policies, insurers are increasingly excluding drugs from their formularies that they deem to be of low value. Our objective was to identify and review empirical evaluations of drug exclusion policies and examine how they affected patients and healthcare costs. ⋯ Although there were important exceptions, most studies found that drug exclusion policies reduced costs and did not negatively impact patients.